Stock listing

29TA Stock Price, News, Filings & Events — Therapeuticsmd, Inc.

Selected listing: 29TA · DUS · EUR · DE

This page tracks Therapeuticsmd, Inc.'s 29TA:DUS listing on DUS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 29TA:DUS. 29TA:DUS is the stock-level entry point for investors researching Therapeuticsmd, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. TherapeuticsMD, Inc. (Ticker: TXMD) is a public company based in the United States, focusing on women's health. With a market capitalization of approximately $23.8 million, the company is engaged in developing and commercializing innovative products for healthcare needs.

29TA:DUSEURDEUpdated September 11, 2026
Therapeuticsmd, Inc. logo
Ticker
29TA:DUS
Asset type
Stock
Market cap
$25.0M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
DUS
Currency
EUR

Therapeuticsmd, Inc. 29TA:DUS stock context

This page tracks Therapeuticsmd, Inc.'s 29TA:DUS listing on DUS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 29TA:DUS. 29TA:DUS is the stock-level entry point for investors researching Therapeuticsmd, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. TherapeuticsMD, Inc. (Ticker: TXMD) is a public company based in the United States, focusing on women's health. With a market capitalization of approximately $23.8 million, the company is engaged in developing and commercializing innovative products for healthcare needs.

Latest news from Therapeuticsmd, Inc.

All Therapeuticsmd, Inc. news →

Therapeuticsmd, Inc. earnings calls

Research Therapeuticsmd, Inc.

Alternate listings